Topics

IO/Targeted Combos Poised to Enter Metastatic Urothelial Carcinoma Paradigm

13:37 EDT 26 Mar 2020 | OncLive

Daniel P. Petrylak, MD, discusses the current treatment landscape of metastatic urothelial carcinoma and exciting strategies in the pipeline.

Original Article: IO/Targeted Combos Poised to Enter Metastatic Urothelial Carcinoma Paradigm

NEXT ARTICLE

More From BioPortfolio on "IO/Targeted Combos Poised to Enter Metastatic Urothelial Carcinoma Paradigm"

Quick Search